InsidersTradesSigma
Follow the PRO MEDEX stock price and the full directors' dealings record of the company, a listed equity based in Saudi Arabia. Shares are quoted on the SA market, under the supervision of Tadawul (CMA). Operating in the Health Care sector, PRO MEDEX has logged 6 insider filings. Market capitalisation: €291.4m. The latest transaction was reported on 31 May 2026 (Board / executive change). All data is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 6,569 of 28,932 companies
65.2
score / 100
Value63
Quality68
FCF yld-8.2%
Earn yld15%
EV/EBITDA7.5x
ROE32%
Gross mgn44%
Net mgn10.0%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 May 2026
About PRO MEDEX
PRO MEDEX is a company focused on the health and pharmaceutical sector, providing innovative solutions for patient well-being. It is listed on the XSAU market.